发明名称 |
Drug condensation aerosols and kits |
摘要 |
The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 μm, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided, wherein the device, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Methods for use are also disclosed. |
申请公布号 |
US9211382(B2) |
申请公布日期 |
2015.12.15 |
申请号 |
US201213569006 |
申请日期 |
2012.08.07 |
申请人 |
Alexza Pharmaceuticals, Inc. |
发明人 |
Hale Ron L.;Hodges Craig C.;Lloyd Peter M.;Lu Amy T.;Myers Daniel J.;Rabinowitz Joshua D.;Wensley Martin J.;McKinney Jeffrey A.;Zaffaroni Alejandro C. |
分类号 |
A61K9/12;A61K9/14;A61M15/00;H05B3/00;A61M11/04;A61K9/00;A61K31/4468;A61K31/519;A61K31/5415;A61K31/5517;A61K31/553 |
主分类号 |
A61K9/12 |
代理机构 |
Swanson & Bratschun, L.L.C. |
代理人 |
Swanson & Bratschun, L.L.C. |
主权项 |
1. A drug supply article comprising:
a heat-conductive substrate having an impermeable surface; a drug composition comprising the drug coated on at least a portion of the surface in the form of a film, wherein said film is a solid having a thickness; and a heat source operable to supply heat to the substrate at a rate that achieves a temperature sufficient to vaporize all or a portion of the coated drug composition within a period of 2 seconds; wherein the vaporized drug composition comprises a therapeutically effective amount of the drug; wherein the film has a thickness between 0.05 and 20 microns; wherein the drug is selected from the group consisting of alprazolam, fentanyl, loxapine, prochlorperazine and zaleplon. |
地址 |
Mountain View CA US |